Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Subcutaneous Injection Batch Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Subcutaneous Injection Batch Manufacturing – V 2.0

Standard Operating Procedure for Subcutaneous Injection Batch Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/023/2025
Supersedes SOP/SIM/023/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP describes the detailed process for the batch manufacturing of subcutaneous (SC) injection products in a sterile manufacturing environment, in accordance with GMP and regulatory standards to ensure product safety, efficacy, and batch-to-batch consistency.

2. Scope

This

SOP is applicable to all activities involved in the preparation, filtration, aseptic filling, sealing, and packaging of SC injection products manufactured within the sterile injectable department.

3. Responsibilities

  • Manufacturing Officer: Executes formulation, filling, and documentation as per BMR.
  • Quality Assurance Officer: Monitors compliance and reviews records.
  • Microbiologist: Conducts environmental and sterility monitoring.
  • Maintenance Engineer: Ensures equipment functionality and preventive maintenance.
See also  Quality Assurance: SOP for Approving New Packaging Materials for Injectable Products - V 2.0

4. Accountability

The Head of Manufacturing is accountable for implementation, compliance, and final batch release readiness.

5. Procedure

5.1 Pre-Manufacturing Checks

  1. Ensure the manufacturing area is cleaned and sanitized. Record in area cleaning log.
  2. Verify calibration status and cleanliness of equipment to be used.
  3. Ensure availability of approved BMR and verify raw material quantities.

5.2 Formulation Preparation

  1. Transfer pre-weighed materials from dispensing to manufacturing via pass box.
  2. Dissolve APIs and excipients in Water for Injection (WFI) in SS316L compounding vessel.
  3. Maintain temperature (if required) and stir with validated agitator until homogenous.
  4. Record batch number, temperature, pH, and mixing time in Annexure-1.

5.3 Filtration and Sterile Transfer

  1. Filter solution through 0.45 µm and then 0.22 µm sterile-grade membrane filters.
  2. Use sterile tubing and transfer the solution aseptically to the filling vessel under LAF.
  3. Perform pre- and post-filtration integrity tests. Record in Annexure-2.

5.4 Aseptic Filling and Sealing

  1. Load cleaned and sterilized vials or prefilled syringes into filling line.
  2. Fill the formulation as per volume specifications under Grade A environment.
  3. Seal using pre-validated capping or plunger-sealing equipment.
  4. Inspect filled containers visually for particles, leaks, and proper volume (Annexure-3).
See also  Sterile Injectable Manufacturing: SOP for Training Personnel in Aseptic Manufacturing - V 2.0

5.5 In-Process Controls

  1. Verify volume fill accuracy, appearance, and clarity of solution every 30 minutes.
  2. Check environmental conditions – temperature, humidity, differential pressure.
  3. Record all results in Annexure-4: IPC Log.

5.6 Batch Completion

  1. Transfer filled units to quarantine area labeled as “Under QC.”
  2. Clean the equipment and area according to respective cleaning SOPs.
  3. Ensure BMR entries are completed and signed by QA and production.

6. Abbreviations

  • SC: Subcutaneous
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • WFI: Water for Injection
  • LAF: Laminar Air Flow

7. Documents

  1. Batch Manufacturing Log – Annexure-1
  2. Filter Integrity Report – Annexure-2
  3. Visual Inspection Report – Annexure-3
  4. In-Process Control Log – Annexure-4

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO GMP for Sterile Pharmaceutical Products
  • Schedule M – Indian Drugs & Cosmetics Act
See also  Sterile Injectable Manufacturing: SOP for Barcode Verification during Dispensing - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Deepa Nair Ravi Deshmukh Dr. Vandana Shah
Designation Production Officer QA Executive QA Head
Department Manufacturing Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Batch Manufacturing Log

Date Batch No. pH Temp (°C) Mix Time Operator
17/06/2025 SC/0625/07 6.2 25 45 min Suraj Patil

Annexure-2: Filter Integrity Report

Filter ID Type Pre-Test Post-Test Status
FILT-SC-02 0.22 µm Pass Pass Pass

Annexure-3: Visual Inspection Report

Unit No. Clarity Foreign Particles Seal Result
SC00741 Clear Absent Intact Pass

Annexure-4: In-Process Control Log

Time Fill Volume Clarity Temp (°C) Remarks
10:30 0.9 mL Clear 24.5 OK

Revision History

Revision Date Revision No. Details Reason Approved By
12/01/2022 1.0 Initial Issue New SOP QA Head
18/06/2025 2.0 Updated for latest validation procedures and annexures Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Aerosol: SOP for Preparing for Regulatory Inspections in Aerosol Manufacturing – V 2.0
Next Post: Analytical Method Development: Dissolution Media Selection SOP – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version